CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

Oncotarget (2017-12-08)

Runzhou Zhuang, Di Lu, Jianyong Zhuo, Xuanyu Zhang, Kun Wang, Xuyong Wei, Qiang Wei, Wei Wang, Haiyang Xie, Lin Zhou, Xiao Xu, Shusen Zheng

PMID29212264

ZUSAMMENFASSUNG

CR6-interacting factor 1 (CRIF1) regulates cell cycle progression and the DNA damage response. Here, we show that CRIF1 expression is decreased in hepatocellular carcinoma (HCC) tissues and positively correlates with patients' survival.

MATERIALIEN

Produktnummer

Marke

Produktbeschreibung

A5441

Sigma-Aldrich

Monoklonales Anti-β-Aktin in Maus hergestellte Antikörper, clone AC-15, ascites fluid

EHU016511

Sigma-Aldrich

MISSION^® esiRNA, targeting human CHN1

EHU008661

Sigma-Aldrich

MISSION^® esiRNA, targeting human GADD45GIP1